Clearmind Medicine Statistics
Total Valuation
CMND has a market cap or net worth of $4.95 million. The enterprise value is -$848,101.
Important Dates
The next estimated earnings date is Thursday, June 12, 2025, before market open.
| Earnings Date | Jun 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CMND has 5.13 million shares outstanding. The number of shares has increased by 582.94% in one year.
| Current Share Class | 5.13M |
| Shares Outstanding | 5.13M |
| Shares Change (YoY) | +582.94% |
| Shares Change (QoQ) | +10.00% |
| Owned by Insiders (%) | 2.50% |
| Owned by Institutions (%) | 5.26% |
| Float | 4.66M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.61 |
| P/TBV Ratio | 1.83 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.72, with a Debt / Equity ratio of 0.02.
| Current Ratio | 1.72 |
| Quick Ratio | 1.64 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -139.62 |
Financial Efficiency
Return on equity (ROE) is -125.61% and return on invested capital (ROIC) is -91.12%.
| Return on Equity (ROE) | -125.61% |
| Return on Assets (ROA) | -43.89% |
| Return on Invested Capital (ROIC) | -91.12% |
| Return on Capital Employed (ROCE) | -204.75% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.24M |
| Employee Count | 4 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CMND has paid $215,801 in taxes.
| Income Tax | 215,801 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -33.99% in the last 52 weeks. The beta is -1.36, so CMND's price volatility has been lower than the market average.
| Beta (5Y) | -1.36 |
| 52-Week Price Change | -33.99% |
| 50-Day Moving Average | 1.06 |
| 200-Day Moving Average | 1.30 |
| Relative Strength Index (RSI) | 43.85 |
| Average Volume (20 Days) | 589,199 |
Short Selling Information
The latest short interest is 117,828, so 2.29% of the outstanding shares have been sold short.
| Short Interest | 117,828 |
| Short Previous Month | 184,432 |
| Short % of Shares Out | 2.29% |
| Short % of Float | 2.53% |
| Short Ratio (days to cover) | 2.54 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -5.86M |
| Pretax Income | -6.68M |
| Net Income | -4.96M |
| EBITDA | -5.85M |
| EBIT | -5.86M |
| Earnings Per Share (EPS) | -$1.29 |
Full Income StatementBalance Sheet
The company has $5.92 million in cash and $45,997 in debt, giving a net cash position of $5.87 million or $1.14 per share.
| Cash & Cash Equivalents | 5.92M |
| Total Debt | 45,997 |
| Net Cash | 5.87M |
| Net Cash Per Share | $1.14 |
| Equity (Book Value) | 2.85M |
| Book Value Per Share | 0.61 |
| Working Capital | 2.69M |
Full Balance SheetCash Flow
| Operating Cash Flow | -4.66M |
| Capital Expenditures | n/a |
| Free Cash Flow | -4.66M |
| FCF Per Share | -$0.91 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |